Correlation Between Mega Lifesciences and CP ALL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mega Lifesciences and CP ALL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mega Lifesciences and CP ALL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mega Lifesciences Public and CP ALL Public, you can compare the effects of market volatilities on Mega Lifesciences and CP ALL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mega Lifesciences with a short position of CP ALL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mega Lifesciences and CP ALL.

Diversification Opportunities for Mega Lifesciences and CP ALL

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Mega and CPALL-R is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Mega Lifesciences Public and CP ALL Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CP ALL Public and Mega Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mega Lifesciences Public are associated (or correlated) with CP ALL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CP ALL Public has no effect on the direction of Mega Lifesciences i.e., Mega Lifesciences and CP ALL go up and down completely randomly.

Pair Corralation between Mega Lifesciences and CP ALL

Assuming the 90 days trading horizon Mega Lifesciences Public is expected to under-perform the CP ALL. In addition to that, Mega Lifesciences is 1.57 times more volatile than CP ALL Public. It trades about -0.31 of its total potential returns per unit of risk. CP ALL Public is currently generating about -0.13 per unit of volatility. If you would invest  6,425  in CP ALL Public on August 29, 2024 and sell it today you would lose (200.00) from holding CP ALL Public or give up 3.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Mega Lifesciences Public  vs.  CP ALL Public

 Performance 
       Timeline  
Mega Lifesciences Public 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mega Lifesciences Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward-looking signals remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
CP ALL Public 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in CP ALL Public are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable essential indicators, CP ALL is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Mega Lifesciences and CP ALL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mega Lifesciences and CP ALL

The main advantage of trading using opposite Mega Lifesciences and CP ALL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mega Lifesciences position performs unexpectedly, CP ALL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CP ALL will offset losses from the drop in CP ALL's long position.
The idea behind Mega Lifesciences Public and CP ALL Public pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum